卵巢癌的非手术疗法研究进展  

Research Progress of Non-surgical Therapy for Ovarian Cancer

作　　者：赵楠楠 刘玲 周青 ZHAO Nannan;LIU Ling;ZHOU Qing(Department of Oncology,Hospital of Traditional Chinese Medicine of Liaocheng City,Liaocheng 252000,China)

机构地区：[1]聊城市中医医院肿瘤科,山东聊城252000

出　　处：《医学综述》2023年第2期275-279,285,共6页Medical Recapitulate

基　　金：山东省中医药科技发展计划项目(2019-0882)。

摘　　要：卵巢癌起病隐匿,早期多无明显特异性症状,且我国肿瘤疾病不规范治疗普遍存在、基层医院诊疗水平参差不齐、诊疗均质化程度低,导致多数患者得不到早期诊断和规范治疗,预后较差。目前一致认为,对于晚期、发生癌细胞转移等的卵巢癌患者,使用手术治疗难以达到理想效果。随着非手术疗法的不断更新,卵巢癌患者的临床疗效、近远期生存情况均得到一定程度的改善。但由于该病的发生发展受年龄、免疫力、临床分期等多种因素的影响,个体间疗效及预后存在较大差异。因此,非手术疗法的选择在卵巢癌的治疗中意义巨大,且有望成为未来治疗卵巢癌的重点研究方向。Due to the occipitousness of onset and the absence of obvious specific symptoms in the early stage of ovarian cancer,the prevalence of non-standard treatment of tumor diseases in China,the uneven level of diagnosis and treatment in primary hospitals,and the low degree of diagnosis and treatment homogenization,most patients can not receive early diagnosis and standard treatment,and the prognosis is poor.Currently,there is a consensus that it is difficult to achieve ideal results in the treatment of advanced and metastatic ovarian cancer patients.With the continuous update of non-surgical therapy,the clinical efficacy and short-term and long-term survival of ovarian cancer patients have been improved to a certain extent.However,because the occurrence and development of the disease is by various factors,such as age,immunity,and clinical stage,there are large differences in the efficacy and prognosis among individuals.Therefore,the choice of non-surgical therapy is of great significance in the treatment of ovarian cancer,and is expected to become the focus of future research in the treatment of ovarian cancer.

关 键 词：卵巢癌 腹腔热灌注化疗 新辅助化疗 抗血管生成治疗 聚ADP核糖聚合酶抑制剂治疗 结合靶向疗法 激素维持疗法 

分 类 号：R737.31[医药卫生—肿瘤]